Wire-free 3D
FFR Guidance
for Every Case
The CathWorks FFRangio™ System optimizes the treatment of coronary artery disease. With FFRangio, clinicians can leverage the proven benefits of objective multi-vessel FFR guidance without the need for traditional invasive pressure wires or drug stimulation.
Learn More about FFRangioOur Investors
CathWorks is backed by a strong group of investing partners.
Play Now
Physician Perspectives
CVIT 2021: Dr. Rahul P. Sharma, Interventional Cardiologist and Director of Structural Interventions at Stanford Medical Center, shares his experience with FFRangio, including important clinical evidence and the benefits of FFRangio for routine clinical practice.
